
Boston Medical Group Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.8/10
Best for: men's health brand selling compounded semaglutide or tirzepatide at one flat price across every dose
Price is where Boston Medical Group scores best in our breakdown.
Semaglutide
Tirzepatide
Price checked on Boston Medical Group’s site,
What the monthly price covers
Medication
Included
Provider visits
Billed separately
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
Boston Medical Group sells compounded GLP-1s through its online pharmacy storefront at 'as low as' $99/mo for semaglutide and $149/mo for tirzepatide, flat across every dose strength, with each plan sold as four weeks of medication rather than a calendar month. The same page also advertises 'Doctor-Led Weight Loss Plans Starting at $190/month', a figure that matches neither product card.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Boston Medical Group
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology

from $99/mo (12-month plan rate) · no insurance needed
Boston Medical Group at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $99/mo (12-month plan rate)
- What's included
- Medication
- Availability
- 7 states
- FDA status
- No FDA warning letter on record
How we scored Boston Medical Group
Each dimension is scored algorithmically from Boston Medical Group’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
9.2/10At $99/mo (12-month plan rate), Boston Medical Group runs about 45% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide).
Effectiveness25%
8.2/10Boston Medical Group offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.
User Experience15%
7.0/10Online intake and platform experience; 3 platform features disclosed.
Trust & Safety15%
8.2/10Key details fully confirmed by our editors; no FDA warning letters on file.
Accessibility10%
5.7/10Boston Medical Group operates in a limited 7-state footprint, so check availability first.
Support10%
6.0/10Boston Medical Group provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Boston Medical Group review
Last checked November 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in 7 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.
What we checked
- Provider's own pricing page
- $99–$149/mo across 2 dose/plan tiers (checked November 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Boston Medical Group
We walked Boston Medical Group’s public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Call to set up a quick consultation for a weight-loss plan.
- 2A licensed physician conducts a required telemedicine consultation and prescribes a personalized program.
- 3Prescription medication ships to you in discreet packaging.
- Pricing published before intake but varies by page: semaglutide 'as little as $199/mo' (12-week $699) on one page, '$299/mo' (12-week $999, includes $100 platform fee) on another.
- Enrollment is phone-first ('call to set up a consultation') rather than a self-serve web questionnaire.
- A telemedicine consultation with a licensed physician is explicitly required before any prescription.
- No lab-testing requirement or refund/cancellation policy is stated.
- Tirzepatide is named as an option but has no separate product page or price.
Boston Medical Group customer support
- Phone
- (800) 337-7555
GLP-1 medications Boston Medical Group offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Ready to get started?
Plans and promotions change often, so check Boston Medical Group's current pricing and active discounts before you decide.
What we like
- Aggressively low monthly pricing
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
Watch-outs
- Limited public information on program details
Boston Medical Group: a low headline price built around a fixed program
Boston Medical Group is an established telehealth practice (run out of a corporate headquarters in Huntington Beach, California, not Boston, despite the name) that sells semaglutide as a structured three-month weight-loss program rather than an open-ended monthly subscription. The reason most people land here is the number: at $99 a month (12-month plan rate) it advertises one of the lowest entry prices in the GLP-1 space, well under the category median of $179. If you are shopping purely on sticker price and want compounded medication without a lot of frills, it fits that brief. Just go in clear-eyed about what that low figure does and doesn't include.
How we get the market median: $179 is the middle value of each program's lowest listed ongoing monthly price for compounded semaglutide (month to month, not a first-month promo, a prepaid plan or a price with a membership on top), across the 121 programs that publish one.
How the pricing works
This part trips people up. The $99 (12-month plan rate) headline covers the medication, but the consultation is not bundled in. A separate telemedicine platform fee is billed on top of the drug cost. The initial phone consult is free, which helps, but the ongoing platform charge is the line item that raises your monthly spend above the advertised rate. There is no first-month teaser price to lure you in; the rate is the rate. Because the program is sold in a fixed multi-month block rather than month to month, you are committing to a course up front rather than paying as you go. Price the whole program, not just the first invoice.
Pricing in this corner of the market moves fast, and Boston Medical Group's published rate has changed more than once. Before you hand over a card, confirm the current monthly figure, the platform fee, and the total program cost on the provider's own checkout rather than relying on a number quoted somewhere else.
The medications and how they're dispensed
Boston Medical Group prescribes compounded semaglutide and tirzepatide, the same two active ingredients found in the brand-name injectables, made by a compounding pharmacy rather than the original manufacturer. There is no brand-name Wegovy, Ozempic, or Zepbound option and no oral tablet; this is injectable compounded medication only. Compounding is what makes the low price possible, but it also means the product isn't FDA-approved the way the brand pens are, so it sits in a more lightly regulated lane. To its credit, there are no FDA warning letters or enforcement actions on file against this provider.
Where it operates
This is a regional service, not a nationwide one. Boston Medical Group treats patients in seven states: California, Texas, Washington, Michigan, New York, Colorado, and Florida. If you live outside those, you simply can't enroll, so check the list before you get attached to the price. Seven is the real footprint, whatever an older listing might claim. If you live outside those seven states, TRYM Health ships compounded GLP-1 vials to all 50, though it doesn't name its pharmacy either.
Its strengths, and what's missing
Its main draw is aggressive pricing on compounded GLP-1s from a practice that has been operating in men's and general health for years, paired with a free initial phone consult. For a budget-conscious shopper in one of its seven states, that combination is the whole pitch.
What's missing is detail. Compared with providers that spell out their compounding pharmacy, accreditation, dose-titration schedule, included clinician messaging, and refund terms, Boston Medical Group publishes relatively little about the mechanics of the program. It doesn't name a compounding-pharmacy partner or cite an accreditation, which means you're trusting the brand rather than a documented supply chain. That isn't a red flag on its own, but it is a gap. Then there's Cora Health, which lists both of its 503A pharmacies, one of them PCAB-accredited, though the company only launched in 2026. It's also the main reason this provider doesn't score higher in our scoring methodology.
Who should choose it
- Budget-first shoppers who want the lowest realistic entry price on compounded semaglutide or tirzepatide
- Residents of CA, TX, WA, MI, NY, CO, or FL, the only states served
- People comfortable with compounded (non-brand) medication and a fixed multi-month program rather than month-to-month flexibility
- Anyone who values a free initial phone consultation before committing
Who should skip it
- Anyone who needs brand-name Wegovy, Ozempic, Mounjaro, or Zepbound, since none are offered here
- Patients outside the seven covered states
- Shoppers who want full transparency on the pharmacy, accreditation, and exact program terms before paying
- People who want true pay-as-you-go billing or an all-in price with no separate platform fee
Trust and medical oversight
Boston Medical Group is a long-running medical practice with a clean regulatory record and no FDA warnings on file. Care is delivered by prescribing clinicians, and the free initial phone consult is a reasonable on-ramp. The limitation is documentation. With no published compounding partner or accreditation detail, you're relying on the practice's track record rather than a fully transparent supply chain. That's enough for a budget pick, but not enough to call it a best-in-class oversight model.
Bottom line
Boston Medical Group is a price play. If you live in one of its seven states, want compounded semaglutide or tirzepatide, and are willing to commit to a fixed multi-month program, the $99 (12-month plan rate) starting rate is hard to beat. Just remember to add the separate platform fee to get your true cost, and check the live pricing before you pay. If you need brand-name medication, nationwide access, month-to-month flexibility, or detailed transparency about the pharmacy behind your prescription, you'll be better served elsewhere.
The Bottom Line
Price is where Boston Medical Group scores best in our breakdown.
Ready to start with Boston Medical Group?
From $99/mo (12-month plan rate). See current pricing and start your free consultation.
Boston Medical Group might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider altRX.
- If you want built-in coaching and behavior-change support, consider Ro.
- If you live outside its coverage area and need nationwide access, consider CoreAge Rx.
Head-to-head
Compare Boston Medical Group vs…
Boston Medical Group scores7.8/10
Side-by-side pricing, medications and scores. Pick a matchup.
Boston Medical Group vs Amazon One Medical
Amazon One Medical scores 8.5/10

Boston Medical Group vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Boston Medical Group review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Boston Medical Group's current pricing
Plans from $99/mo (12-month plan rate). Start your free consultation to check eligibility and today's price.